Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Researchers identify molecular switch that impacts immune responses to viral infections

Walter and Eliza Hall Institute researchers have identified a molecular switch that impacts immune responses to viral infections, and whether or not protective antibodies are produced.

14 Aug 2019

Scientists step closer to an Ebola cure

The Ebola virus has killed thousands of people in Western Africa between 2014 and 2016. Recently, another outbreak in Congo emerged, killing roughly a thousand people. Now, scientists are a step closer to an Ebola cure, thanks to two new drugs that appear to be highly effective in treating people with the virus.

13 Aug 2019

Human apolipoprotein E promotes hepatitis B virus infection

Human apolipoprotein E (apoE) promotes hepatitis B virus (HBV) infection and production, according to a study published DATE in the open-access journal PLOS Pathogens by Luhua Qiao and Guangxiang (George) Luo of the University of Alabama at Birmingham School of Medicine.

From PLOS ONE 13 Aug 2019

Scientists point to enterovirus infection as cause for acute flaccid myelitis

Scientists at the Center for Infection and Immunity at Columbia University Mailman School of Public Health, the U.S. Centers for Disease Control and Prevention, and the University of California San Diego report antibody evidence in cerebrospinal fluid that points to enterovirus infection as a cause for acute flaccid myelitis, a disease responsible for partially paralyzing more than 560 children in the United States since 2014. Results of the study appear in the journal mBio.

13 Aug 2019

Antibody target implicated in neuropsychiatric symptoms of lupus discovered

Researchers have identified a specific target of antibodies that are implicated in the neuropsychiatric symptoms of lupus, according to human research published in JNeurosci.

From Society for Neuroscience 13 Aug 2019

Study provides evidence that enterovirus may be a factor in acute flaccid myelitis

A new study analyzing samples from patients with and without acute flaccid myelitis provides additional evidence for an association between the rare but often serious condition that causes muscle weakness and paralysis, and infection with non-polio enteroviruses.

13 Aug 2019

Study highlights how high fat diet affects one component of gut immune system

Researchers have discovered how our choice of diet can weaken our gut immune system and lead to the development of diabetes.

13 Aug 2019

Breakthrough study identifies specific antibody target implicated in neuropsychiatric lupus

A breakthrough study by a SUNY Downstate Health Sciences University research team has identified a specific antibody target implicated in neuropsychiatric symptoms of lupus.

13 Aug 2019

Antibody may help the immune system fight sepsis-related fungal infections

An antibody that blocks the "programmed cell death" pathway may help the immune system fight off sepsis-related fungal infections, according to animal studies reported in SHOCK: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, Official Journal of the Shock Society.

12 Aug 2019

Innovative technology could help treat cancer more selectively and effectively

Treating cancer more selectively and more effectively - this could be achieved with an innovative technology developed by teams of researchers at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie and the Ludwig-Maximilians-Universität München.

9 Aug 2019

Encapsulating two drugs in same nanovector can greatly improve drug delivery

Encapsulating two drugs with different properties into nanovesicles surrounded by antibodies can greatly improve their delivery and efficacy, according to a study led by Xavier Fernández Busquets, director of the joint Nanomalaria unit at the Institute for Bionengineering of Catalonia and the Barcelona Institute for Global Health, an institution supported by "la Caixa"

9 Aug 2019

Study reveals Lassa virus' soft spot

As this year's Lassa fever outbreak in Nigeria is finally ebbing, the total tally came to more than 600 infected people, one-quarter of them dead. Thousands more die each year, uncounted in rural villages throughout West Africa.

9 Aug 2019

Innovative technology could treat cancer more selectively and effectively

9 Aug 2019

Beckman Coulter Life Sciences publishes ClearLLab Control Cells white paper

Beckman Coulter Life Sciences has published a flow cytometry white paper to support the gating strategies behind its newly launched IVD ClearLLab Control Cells.

From Beckman Coulter Life Sciences - Flow Cytometry 6 Aug 2019

Beckman Coulter Life Sciences introduces free online DURA Innovations calculator tool

Beckman Coulter launch online DURA Innovations tool, a powerful cost benefit analysis resource to accompany its latest Cost Benefit Calculator Handbook.

From Beckman Coulter Life Sciences - Flow Cytometry 6 Aug 2019

Quanterix corporation releases operating results for second quarter 2019

Quanterix announced financial results for the three and six months ended June 30, 2019.

From Quanterix 6 Aug 2019

New nanovaccine for deadly skin cancer

Tel Aviv scientists have published their version of a vaccine against the deadly skin cancer malignant melanoma, which arises from the pigment producing cells of the skin. This is the most feared form of skin cancer, with a high tendency to metastasize to distant parts of the body, including the brain.

6 Aug 2019

Biomarkers reveal increase in thyroid cancer incidence among WTC responders

The incidence of thyroid cancer among first responders who volunteered or were employed as firefighters, rescue personnel and cleanup workers at Ground Zero in New York on or after September 11, 2001, is three times higher than that in the general population.

5 Aug 2019

Whole body vibration adjusts the microbiome and immune cells to deter inflammation in diabetes

In the face of diabetes, a common condition in which glucose and levels of destructive inflammation soar, whole body vibration appears to improve how well our body uses glucose as an energy source and adjust our microbiome and immune cells to deter inflammation, investigators report.

5 Aug 2019

GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

Under the leadership of Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the George Washington University Cancer Center, the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.

3 Aug 2019